Albers Jeffrey W.'s Form 4 filing
Blueprint Medicines Corp (BPMC) · filed Nov 12, 2024
- Accession no.
- 0001415889-24-026594
- Filed
- Nov 12, 2024
- Trade date
- Nov 7, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $510.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Albers Jeffrey W.CIK 0001638474 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2024 | Common Stock | MOption exerciseAcquired | +5,000 | $36.05 | +$180,250 | 162,557 | Direct | |
| Nov 7, 2024 | Common Stock | SSaleDisposed | −5,000 | $102.00 | −$510,000 | 157,557 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2024 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 135,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.